共 50 条
- [41] De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant studyANNALS OF ONCOLOGY, 2019, 30 (06) : 921 - 926Guarneri, V论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy Ist Oncol Veneto IOV IRCCS, Med Oncol 2, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyDieci, M., V论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy Ist Oncol Veneto IOV IRCCS, Med Oncol 2, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyBisagni, G.论文数: 0 引用数: 0 h-index: 0机构: Azienda USL IRCCS Reggio Emilia, Oncol Unit, Dept Oncol & Adv Technol, Reggio Emilia, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyFrassoldati, A.论文数: 0 引用数: 0 h-index: 0机构: S Anna Univ Hosp, Dept Morphol Surg & Expt Med, Clin Oncol, Ferrara, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyBianchi, G., V论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS, Ist Nazl Tumori, Med Oncol 1, Milan, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyDe Salvo, G. L.论文数: 0 引用数: 0 h-index: 0机构: Ist Oncol Veneto IOV IRCCS, Clin Trials & Biostat Unit, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyOrvieto, E.论文数: 0 引用数: 0 h-index: 0机构: Azienda ULSS 5 Polesana, Pathol Unit, Rovigo, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyUrso, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyPascual, T.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain Inst Invest Biomed August Pi & Sunyer IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumours, Barcelona, Spain Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyPare, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain Inst Invest Biomed August Pi & Sunyer IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumours, Barcelona, Spain Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyGalvan, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain Inst Invest Biomed August Pi & Sunyer IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumours, Barcelona, Spain Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyAmbroggi, M.论文数: 0 引用数: 0 h-index: 0机构: Osped G da Saliceto, Dept Oncol Hematol, Piacenza, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyGiorgi, C. A.论文数: 0 引用数: 0 h-index: 0机构: Ist Oncol Veneto IOV IRCCS, Med Oncol 2, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyMoretti, G.论文数: 0 引用数: 0 h-index: 0机构: Azienda USL IRCCS Reggio Emilia, Oncol Unit, Dept Oncol & Adv Technol, Reggio Emilia, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy论文数: 引用数: h-index:机构:Vicini, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Modena & Reggio Emilia, Stat Unit, Dept Diagnost & Clin Med & Publ Hlth, Modena, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyPrat, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain Inst Invest Biomed August Pi & Sunyer IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumours, Barcelona, Spain Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, ItalyConte, P. F.论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy Ist Oncol Veneto IOV IRCCS, Med Oncol 2, Padua, Italy Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
- [42] Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patientsMOLECULAR NUTRITION & FOOD RESEARCH, 2017, 61 (11)Jaskulski, Stefanie论文数: 0 引用数: 0 h-index: 0机构: German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyJung, Audrey Y.论文数: 0 引用数: 0 h-index: 0机构: German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyRudolph, Anja论文数: 0 引用数: 0 h-index: 0机构: German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyJohnson, Theron论文数: 0 引用数: 0 h-index: 0机构: German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyThoene, Kathrin论文数: 0 引用数: 0 h-index: 0机构: Univ Canc Ctr Hamburg, Dept Canc Epidemiol, Clin Canc Registry, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyHerpel, Esther论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Pathol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanySinn, Peter论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ Hosp, Dept Pathol, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyChang-Claude, Jenny论文数: 0 引用数: 0 h-index: 0机构: German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf, Genet Tumour Epidemiol Grp, Hamburg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
- [43] Costs of breast cancer recurrence after initial treatment for HR+, HER2-, high-risk early breast cancer: estimates from SEER-Medicare linked dataJOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 84 - 96Vitko, Alexandra S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USAMartin, Pam论文数: 0 引用数: 0 h-index: 0机构: Med Decis Modeling Inc, Indianapolis, IN USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USAZhang, Sheng论文数: 0 引用数: 0 h-index: 0机构: Med Decis Modeling Inc, Indianapolis, IN USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USAJohnston, Adam论文数: 0 引用数: 0 h-index: 0机构: Med Decis Modeling Inc, Indianapolis, IN USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USAOhsfeldt, Robert论文数: 0 引用数: 0 h-index: 0机构: Med Decis Modeling Inc, Indianapolis, IN USA Texas A&M Univ, College Stn, TX USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USAZheng, Shen论文数: 0 引用数: 0 h-index: 0机构: TechData Serv Co, King Of Prussia, PA USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USALiepa, Astra M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Corp Ctr, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USA Eli Lilly & Co, Value Evidence & Outcomes VEO Oncol, Indianapolis, IN 46285 USA
- [44] Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrenceEJSO, 2015, 41 (04): : 548 - 552Okumura, Y.论文数: 0 引用数: 0 h-index: 0机构: Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanNishimura, R.论文数: 0 引用数: 0 h-index: 0机构: Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanNakatsukasa, K.论文数: 0 引用数: 0 h-index: 0机构: Kyoto Prefectural Univ Med, Dept Endocrine & Breast Surg, Kyoto, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanYoshida, A.论文数: 0 引用数: 0 h-index: 0机构: St Lukes Int Hosp, Dept Breast Surg, Tokyo, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanMasuda, N.论文数: 0 引用数: 0 h-index: 0机构: Natl Hosp Org Osaka Natl Hosp, Dept Surg, Breast Oncol, Osaka, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanTanabe, M.论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Div Breast Oncol, Tokyo, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanShien, T.论文数: 0 引用数: 0 h-index: 0机构: Okayama Univ Hosp, Dept Breast & Endocrine Surg, Okayama, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanTanaka, S.论文数: 0 引用数: 0 h-index: 0机构: Osaka Med Coll, Dept Gen & Gastroenterol Surg, Sect Breast & Endocrine Surg, Osaka, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanArima, N.论文数: 0 引用数: 0 h-index: 0机构: Kumamoto City Hosp, Dept Pathol, Kumamoto, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanKomoike, Y.论文数: 0 引用数: 0 h-index: 0机构: Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan论文数: 引用数: h-index:机构:Iwase, T.论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Div Breast Oncol, Tokyo, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanInaji, H.论文数: 0 引用数: 0 h-index: 0机构: Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, JapanIshitobi, M.论文数: 0 引用数: 0 h-index: 0机构: Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan
- [45] Biomarker (ER, PR, Her2 and Ki67) Testing On Core Needle Biopsy Specimens From Primary Breast Cancer - Their Usefulness and LimitationsEUROPEAN JOURNAL OF CANCER, 2012, 48 : S92 - S92Nagaoka, H.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanTakahashi, T.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanEndo, K.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanSugitani, K.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanNakagami, K.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanKim, Y.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanYoshida, Y.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanOoki, U.论文数: 0 引用数: 0 h-index: 0机构: Ogawa Redcross Hosp, Dept Surg, Saitama, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanHoriguchi, J.论文数: 0 引用数: 0 h-index: 0机构: Gunma Univ, Dept Thorac & Visceral Organ Surg, Gunma, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, JapanTakeyoshi, I.论文数: 0 引用数: 0 h-index: 0机构: Gunma Univ, Dept Thorac & Visceral Organ Surg, Gunma, Japan Ogawa Redcross Hosp, Dept Surg, Saitama, Japan
- [46] Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2-Breast Cancer: Impact of Tumor Ki67 and ER StatusCHEMOTHERAPY, 2024, 69 (03) : 141 - 149Akdag, Goncagul论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeYildirim, Sedat论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeDogan, Akif论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeYasar, Zeynep Yuksel论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeBal, Hamit论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeKinikoglu, Oguzcan论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeOksuz, Sila论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeOzkerim, Ugur论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeTunbekici, Salih论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeYildiz, Hacer Sahika论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeTurkoglu, Ezgi论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeAlan, Ozkan论文数: 0 引用数: 0 h-index: 0机构: Koc Univ, Sch Med, Div Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeKokten, Sermin Coban论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Pathol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeIsik, Deniz论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeSever, Ozlem Nuray论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeOdabas, Hatice论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeYildirim, Mahmut Emre论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, TurkiyeTuran, Nedim论文数: 0 引用数: 0 h-index: 0机构: Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye Hlth Sci Univ, Kartal Dr Lutfi Kirdar City Hosp, Dept Med Oncol, Istanbul, Turkiye
- [47] Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancerBreast Cancer Research, 24Michael Crager论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologySameera R. Wijayawardana论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologyAaron M. Gruver论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologyAndrea Blacklock论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologyChristy Russell论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologyFrederick L. Baehner论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – OncologyFrancisco Sapunar论文数: 0 引用数: 0 h-index: 0机构: Biostatistics – Exact Sciences Corporation,Global Statistical Sciences – Oncology
- [48] Reliability of core needle biopsy for HER2-low early-stage breast cancerCLINICAL & TRANSLATIONAL ONCOLOGY, 2025,Ciniselli, C. M.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyVerderio, P.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyDuroni, V.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyBaili, P.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Data Sci Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyPizzamiglio, S.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italyde Braud, F. G.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, I-20133 Milan, Italy Univ Milan, Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyFolli, S.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Breast Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyDepretto, C.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Breast Imaging Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyScaperrotta, G.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Breast Imaging Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyDe Santis, M. C.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Breast Unit, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Radiat Oncol 1, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyCarnevale, M. G.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Radiat Oncol 1, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, ItalyDe Marco, C.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Adv Diagnost, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Di Cosimo, S.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Dept Adv Diagnost, I-20133 Milan, Italy Fdn IRCCS Ist Nazl Tumori, Dept Epidemiol & Data Sci, Bioinformat & Biostat Unit, I-20133 Milan, Italy
- [49] Surgical Management of the Axilla in Patients Presenting with Clinically Node Positive Hormone Receptor Positive, HER2 Negative (HR+/HER2-) Breast CancerANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S101 - S101Jasper, Jacob论文数: 0 引用数: 0 h-index: 0机构: Tufts Univ, Medford, MA USA Tufts Univ, Medford, MA USAKantor, Olga论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Hosp, Boston, MA USA Tufts Univ, Medford, MA USADorninici, Laura论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Faulkner Hosp, Dana Farber Canc Inst, Boston, MA USA Tufts Univ, Medford, MA USANakhlis, Faina论文数: 0 引用数: 0 h-index: 0机构: Brigham & Womens Hosp, Boston, MA USA Tufts Univ, Medford, MA USAOgayo, Esther论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Tufts Univ, Medford, MA USANimbkar, Suniti论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Brigham Canc Ctr, South Shore Hosp clin, Boston, MA USA Tufts Univ, Medford, MA USAKurt, Busem Binbogct论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Tufts Univ, Medford, MA USAKing, Tari论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA Tufts Univ, Medford, MA USAMittendorf, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA Tufts Univ, Medford, MA USA
- [50] Risk of Recurrence by Nodal Status and High-Risk Features in Patients with HR+, HER2-, Early Breast Cancer: An Analysis of Real-world DataBREAST, 2025, 80Grimes, B.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USATolaney, S. M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Eli Lilly & Co, Indianapolis, IN USA论文数: 引用数: h-index:机构:Cortes, J.论文数: 0 引用数: 0 h-index: 0机构: Quironsalud Grp, Inst Int Breast Canc Ctr, Dept Med, Pangaea Oncol, Barcelona, Spain Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid, Spain Eli Lilly & Co, Indianapolis, IN USALiepa, A. M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USASugihara, T.论文数: 0 引用数: 0 h-index: 0机构: Syneos Hlth, Morrisville, NC USA Eli Lilly & Co, Indianapolis, IN USACui, Z. Lin论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USAGathirua-Mwangi, W.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USAShahir, A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USAMonaco, M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Eli Lilly & Co, Indianapolis, IN USANeven, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Louvain, Belgium Eli Lilly & Co, Indianapolis, IN USAJohnston, S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, London, England Eli Lilly & Co, Indianapolis, IN USA